NCT04896112: A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid Leukemia |
|
|
| Withdrawn | 1 | 93 | US | LNK01002, LNK-1000318 | Lynk Pharmaceuticals Co., Ltd | Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera | 10/22 | 10/22 | | |
